201 filings
Page 6 of 11
424B5
lawzqoqi vzatavqz
2 Jan 20
Prospectus supplement for primary offering
4:50pm
CORRESP
ub3ta7z3msso5ezn8rs
30 Dec 19
Correspondence with SEC
12:00am
UPLOAD
c8rfz twa6dc6jrl3
27 Dec 19
Letter from SEC
12:00am
8-K
qy3q5o0389wzn2rw8wh
20 Dec 19
Other Events
4:31pm
S-3
sqaqy3cq 341igwi7g
20 Dec 19
Shelf registration
4:17pm
8-K
o3qyntwt0
22 Nov 19
Regulation FD Disclosure
4:16pm
8-K
zoja8bt em
12 Nov 19
UroGen Pharma Reports Third Quarter 2019 Financial Results and Recent
8:06am
8-K
9wralf2fn
12 Nov 19
Entry into a Material Definitive Agreement
7:01am
8-K
ujdg38 4w607e8vk
8 Nov 19
Entry into a Material Definitive Agreement
4:02pm
8-K
vmz3d3jt8m1ns ik
24 Sep 19
Durability of Response Determined to be 89 Percent at Six Months and 84 Percent at 12 Months
5:20pm
8-K
b5uwuu0vl8 q6
9 Aug 19
UroGen Pharma Reports Second Quarter 2019 Financial Results and Recent
8:16am
S-8
ag99wh9i9
7 Jun 19
Registration of securities for employees
5:11pm
8-K
wuakyg5pazcnux
7 Jun 19
Submission of Matters to a Vote of Security Holders
5:00pm
UPLOAD
oiqh0vct
30 May 19
Letter from SEC
12:00am
CORRESP
yh81dutwu 2vgtq
29 May 19
Correspondence with SEC
12:00am
8-K
1kjq8f7u87
28 May 19
Other Events
5:00pm
UPLOAD
uvmu9on
17 May 19
Letter from SEC
12:00am
CORRESP
57v8s
14 May 19
Correspondence with SEC
12:00am